Statement delivered at Panel Discussion on Universal Access to Vaccines – 20th meeting, 49th Regular Session of Human Rights Council
On 10 March 2022, IFPMA Director-General, Thomas Cueni, was invited to address a Panel discussion on ensuring equitable, affordable, timely and universal access for all countries to vaccines in response to the COVID-19 pandemic. The panel discussion took place at the 49th Regular Session of the Human Rights Council.
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
Related news and resources
#AlwaysInnovating: Pharmaceutical Industry Facts & Figures
This compendium of facts and figures aims to provide a snapshot of the contribution of the pharmaceutical industry. Pharmaceutical companies are at the forefront of developing medicines and vaccines that change how we fight and prevent disease and help solve today’s biggest health challenges. In addition to their contribution to healthier societies, pharmaceutical companies also...
Read more
Statement on the revision of the Declaration of Helsinki on ethical principles for medical research
On 19 October 2024, the World Medical Association (WMA) General Assembly unanimously voted to adopt a set of revisions to the Declaration of Helsinki on ethical principles for medical research.
Read moreResumed 12th session of the Intergovernmental Negotiating Body (INB 12)
On 2 December 2024 in Geneva, IFPMA delivered a statement at the resumed INB 12.
Read more